Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Long noncoding RNA PVT1-214 enhances gastric cancer progression by upregulating TrkC expression in competitively sponging way.

Zhao S, Fan NF, Chen XH, Zhuo CH, Xu CW, Lin RB.

Eur Rev Med Pharmacol Sci. 2019 May;23(10):4173-4184. doi: 10.26355/eurrev_201905_17920.

2.

The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer.

Huang T, Liu HW, Chen JQ, Wang SH, Hao LQ, Liu M, Wang B.

Biomed Pharmacother. 2017 Apr;88:302-308. doi: 10.1016/j.biopha.2017.01.049. Epub 2017 Feb 24.

PMID:
28122299
3.

Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.

Feng K, Liu Y, Xu LJ, Zhao LF, Jia CW, Xu MY.

Biomed Pharmacother. 2018 Aug;104:686-698. doi: 10.1016/j.biopha.2018.05.078. Epub 2018 May 25.

PMID:
29803929
4.

Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195.

Wu D, Li Y, Zhang H, Hu X.

Cell Physiol Biochem. 2017;42(6):2453-2466. doi: 10.1159/000480209. Epub 2017 Aug 22.

5.

Long Noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) Promotes Colon Cancer Progression via Endogenous Sponging miR-26b.

Zhang R, Li J, Yan X, Jin K, Li W, Liu X, Zhao J, Shang W, Liu Y.

Med Sci Monit. 2018 Dec 1;24:8685-8692. doi: 10.12659/MSM.910955.

6.

Long Noncoding RNA PVT1 Acts as a "Sponge" to Inhibit microRNA-152 in Gastric Cancer Cells.

Li T, Meng XL, Yang WQ.

Dig Dis Sci. 2017 Nov;62(11):3021-3028. doi: 10.1007/s10620-017-4508-z. Epub 2017 Mar 3.

PMID:
28258379
7.

Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.

Zheng X, Zhao K, Liu T, Liu L, Zhou C, Xu M.

J Cell Biochem. 2019 Mar;120(3):3911-3921. doi: 10.1002/jcb.27673. Epub 2018 Oct 10.

PMID:
30304557
8.

Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.

Guo D, Wang Y, Ren K, Han X.

Exp Cell Res. 2018 Jan 1;362(1):172-179. doi: 10.1016/j.yexcr.2017.11.014. Epub 2017 Nov 11.

PMID:
29133127
9.

LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1.

Tian Z, Cao S, Li C, Xu M, Wei H, Yang H, Sun Q, Ren Q, Zhang L.

J Cell Physiol. 2019 Apr;234(4):4799-4811. doi: 10.1002/jcp.27279. Epub 2018 Oct 14.

PMID:
30317572
10.

Knockdown of long non-coding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.

Shang AQ, Wang WW, Yang YB, Gu CZ, Ji P, Chen C, Zeng BJ, Wu JL, Lu WY, Sun ZJ, Li D.

Am J Physiol Gastrointest Liver Physiol. 2019 May 24. doi: 10.1152/ajpgi.00357.2018. [Epub ahead of print]

PMID:
31125260
11.

Long Noncoding RNA PVT1 Facilitates Cervical Cancer Progression via Negative Regulating of miR-424.

Gao YL, Zhao ZS, Zhang MY, Han LJ, Dong YJ, Xu B.

Oncol Res. 2017 Sep 21;25(8):1391-1398. doi: 10.3727/096504017X14881559833562. Epub 2017 Mar 8.

PMID:
28276314
12.

Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.

Yang Q, Yu Y, Sun Z, Pan Y.

Biomed Pharmacother. 2018 Oct;106:61-67. doi: 10.1016/j.biopha.2018.06.112. Epub 2018 Jun 26.

PMID:
29957467
13.

LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214.

Chen Y, Du H, Bao L, Liu W.

Cancer Biol Med. 2018 Aug;15(3):238-250. doi: 10.20892/j.issn.2095-3941.2017.0174.

14.

Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.

Kong R, Zhang EB, Yin DD, You LH, Xu TP, Chen WM, Xia R, Wan L, Sun M, Wang ZX, De W, Zhang ZH.

Mol Cancer. 2015 Apr 12;14:82. doi: 10.1186/s12943-015-0355-8.

15.

A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.

Zhang Y, Wen DY, Zhang R, Huang JC, Lin P, Ren FH, Wang X, He Y, Yang H, Chen G, Luo DZ.

Cell Physiol Biochem. 2018;47(6):2216-2232. doi: 10.1159/000491534. Epub 2018 Jul 5.

16.

Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer.

Li H, Chen S, Liu J, Guo X, Xiang X, Dong T, Ran P, Li Q, Zhu B, Zhang X, Wang D, Xiao C, Zheng S.

Biochem Biophys Res Commun. 2018 Jan 15;495(3):2350-2355. doi: 10.1016/j.bbrc.2017.12.114. Epub 2017 Dec 23.

PMID:
29277611
17.

The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.

Chen L, Han X, Hu Z, Chen L.

Cancer Chemother Pharmacol. 2019 May;83(5):921-931. doi: 10.1007/s00280-019-03808-3. Epub 2019 Mar 11.

PMID:
30859368
18.

Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.

Zhang Y, Chen Z, Li MJ, Guo HY, Jing NC.

Biomed Pharmacother. 2017 Jan;85:264-271. doi: 10.1016/j.biopha.2016.11.014. Epub 2016 Nov 22.

PMID:
27887846
19.

LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer.

Du P, Hu C, Qin Y, Zhao J, Patel R, Fu Y, Zhu M, Zhang W, Huang G.

J Oncol. 2019 May 8;2019:9325407. doi: 10.1155/2019/9325407. eCollection 2019.

20.

LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.

Yang XZ, Cheng TT, He QJ, Lei ZY, Chi J, Tang Z, Liao QX, Zhang H, Zeng LS, Cui SZ.

Mol Cancer. 2018 Aug 22;17(1):126. doi: 10.1186/s12943-018-0874-1.

Supplemental Content

Support Center